Related Experiment Videos
Fibronectin fragments in osteoarthritic synovial fluid
D L Xie1, R Meyers, G A Homandberg
1Department of Biochemistry, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612-3864.
The Journal of Rheumatology
|September 1, 1992
Summary
Osteoarthritis (OA) patients show elevated fibronectin fragments in synovial fluid. These fragments contribute to cartilage degradation by promoting metalloproteinase release, indicating a key role in arthritis pathology.
Area of Science:
- Biochemistry
- Cell Biology
- Rheumatology
Background:
- Fibronectin is a key extracellular matrix glycoprotein with diverse cellular functions.
- Elevated fibronectin and protease levels are observed in osteoarthritis (OA) joint tissues.
- Fibronectin fragments are implicated in cartilage matrix degradation.
Purpose of the Study:
- To investigate the presence of fibronectin fragments in the synovial fluid (SF) of OA patients.
- To determine the concentration and size of fibronectin fragments in OA SF.
- To explore the pathological implications of fibronectin fragments in arthritis.
Main Methods:
- Analysis of synovial fluid from osteoarthritis patients.
- Quantification of fibronectin fragments using biochemical assays.
- Assessment of fragment sizes (100-200 kDa).
Main Results:
- Fibronectin fragments (100-200 kDa) were detected at concentrations of at least 1 microM in all examined OA SF samples.
- These fragments were found to induce metalloproteinase release from cartilage.
- Fibronectin fragments also enhance metalloproteinase expression in synovial fibroblasts.
Conclusions:
- The presence of significant fibronectin fragments in OA synovial fluid suggests a critical role in disease pathogenesis.
- These fragments contribute to cartilage breakdown and proteoglycan depletion.
- Fibronectin fragments represent a potential therapeutic target for managing arthritis.